M3M3, Inc.2413東証プライムサービス業FY ending Mar 2026, consolidated, IFRS

Which M3 businesses make the profit?

Revenue by business segment, and the profit each one keeps.

Revenue by geography

Geographic revenue reported in annual filings

No geographic revenue breakdown was disclosed.

※ Segment figures include inter-segment sales and do not sum to the company total

Revenue and profit mix

FY ending Mar 2026

Revenue mix

Profit mix (profitable segments)

Medical Platform accounts for 30% of revenue and 48% of profit.

  • Other Emerging Business
    Revenue 0.6%Profit 6.5%Difference +5.9 ptMargin 230.5%
  • Medical Platform
    Revenue 29.6%Profit 47.8%Difference +18.2 ptMargin 34.5%Health Tech
  • Career Solution
    Revenue 6.5%Profit 7.9%Difference +1.4 ptMargin 26.1%HR & Staffing
  • Evidence Solution
    Revenue 6.9%Profit 6.8%Difference -0.1 ptMargin 21.0%CRO & Clinical Testing
  • Overseas
    Revenue 24.7%Profit 19.8%Difference -4.9 ptMargin 17.1%Health Tech
  • Site Solution
    Revenue 15.5%Profit 7.7%Difference -7.8 ptMargin 10.6%Nursing Care
  • Patient Solution
    Revenue 16.2%Profit 3.6%Difference -12.6 ptMargin 4.7%Hospitals & Medical Services

Calculated from disclosed figures; listed by margin. Difference = profit share − revenue share (percentage points). Segment revenues may include inter-segment sales and may not sum to company revenue.

Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.

Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.

Segment history (JPY millions)

SegmentRevenue CAGRFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Medical Platform+6.8%5y—90,19645.6%90,49042.7%88,18138.7%104,04434.5%
Evidence Solution+5.1%5y—26,52728.9%26,38625.4%24,02018.1%24,35421.0%
Career Solution+11.0%5y—13,86933.5%16,60528.8%20,88227.1%22,72426.1%
Site Solution+26.8%5y—34,97910.7%33,01211.3%47,03011.5%54,34610.6%
Overseas+15.6%5y—62,07027.4%69,85216.7%80,50618.3%86,90517.1%
Other Emerging Business-8.2%5y—3,17729.7%2,539-11.4%2,36142.5%2,116230.5%
Patient SolutionN/A———21,9193.8%56,8734.7%

Top: revenue. Bottom: operating margin.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第26期(2025/04/01-2026/03/31)

    ID S100YJ252026-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2024/04/01-2025/03/31)

    ID S100W3NK2025-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第24期(2023/04/01-2024/03/31)

    ID S100TVWH2024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第23期(2022/04/01-2023/03/31)

    ID S100R87E2023-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第22期(令和3年4月1日-令和4年3月31日)

    ID S100OJCD2022-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(令和2年4月1日-令和3年3月31日)

    ID S100LS8W2021-06-28Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.